Rare Disease & Gene Therapy Digest • October 19, 2026 Rare Disease & Gene Therapy Digest October 19, 2026 Merck KGaA agreed to buy Silence Therapeutics for about… Pro Hub Membership Required You must be a Pro Hub member to access this content. Join Now Already a member? Log in here